A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer

Clinical trial NCT01833546 · COMPLETED

Trial details

NCT number: NCT01833546
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Pancreatic Cancer

Start date: 2013-04-18
Primary completion: 2015-08-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.